研究業績

研究業績2016年度 英文原著

詳細

【英文原著】
1. Ando Y., Ueda M. Antibody therapy for familial amyloid polyneuropathy. Amyloid, 2017, in press.

 

2. Huang G., Ueda M., Tasaki M., Yamashita T., Misumi Y., Masuda T., Suenaga G., Inoue Y., Kinoshita Y., Matsumoto S., Mizukami M., Tsuda Y., Nomura T., Obayashi K., Ando Y. Clinicopathological and biochemical findings of thyroid amyloid in hereditary transthyretin amyloidosis with and without liver transplantation. Amyloid, 2017, in press.

 

3. Ikenoshita S., Yamashita S., Sakamoto T., Misumi Y., Ando Y. Hemi-atrophy of tongue with contralateral hemiparesis in a patient with MADSAM. J. Clin. Neurol., 2017, in press.

 

4. Inatomi Y., Nakajima M., Yonehara T., Ando Y. Ipsilateral hemiparesis in ischemic stroke patients. Acta Neurol. Scand., 2017, in press.

 

5. Inatomi Y., Nakajima M., Yonehara T., Ando Y. Clinical characteristics of patients seizure following the 2016 Kumamoto earthquake. J. Clin. Neurosci., 2017, in press.

 

6. Inatomi Y., Nakajima M., Yonehara T., Ando Y. Successful switching of anticoagulants in a patient with superficial siderosis and atrial fibrillation. Neurol. Clin. Nerosci., 2017, in press.

 

7. Inatomi Y., Nakajima M., Yonehara T., Ando Y. Ipsilateral Tremor-Like Grasp Reaction in a Patient with Ischemic Stroke. Cogn. Behav. Neurol., 2017, in press.

 

8. Izaki A., Obayashi K., Suenaga G., Ueda M., Yamashita T., Tasaki M., Yanagisawa Y., Masuda T., Misumi Y., Ando Y. In vitro and in vivo assessment of novel derivatives for detecting various amyloid deposits. Amyloid, 2017, in press.

 

9. Kawano H., Bivard A., Lin L., Ma H., Cheng X., Aviv R., O’Brien B., Butcher K., Lou M., Zhang J., Jannes J., Dong Q., Levi CR., Parsons MW. Perfusion computed tomography in patients with stroke thrombolysis. Brain, 2017, in press.

 

10. Maeda Y., Nakane S., Higuchi O., Nakamura H., Komori A., Migita K., Mukaino A., Umeda M., Ichinose K., Tamai M., Kawashiri SY., Sakai W., Yatsuhashi H., Kawakami A., Matsuo H. Ganglionic acetylcholine receptor autoantibodies in patients with autoimmune diseases including primary biliary cirrhosis. Mod. Rheumatol. 2017, in press.

 

11. Masuda T., Ueda M., Suenaga G., Misumi Y., Tasaki M., Izaki A., Yanagisawa Y., Inoue Y., Motokawa H., Matsumoto S., Mizukami M., Arimura A., Deguchi T., Nishio Y., Yamashita T., Inomata Y., Obayashi K., Ando Y. Early skin denervation in hereditary and iatrogenic transthyretin amyloid neuropathy. Neurology, 2017, in press.

 

12. Matsumoto S., Ueda M., Yamashita T., Amano T., Misumi Y., Tasaki M., Masuda T., Mizukami M., Furuya H., Ando Y. A late-onset case of hereditary transthyretin amyloidosis with a novel compound heterozygous mutation. Amyloid, 2017, in press.

 

13. Misumi Y., Ueda M., Yamashita T., Masuda T., Kinoshita Y., Tasaki M., Nagase T., Ando Y. Novel screening for transthyretin amyloidosis by using fat ultrasonography. Ann. Neurol., 2017, in press.

 

14. Mizukami M., Ueda M., Tasaki M., Misumi Y., Masuda T., Matsumoto S., Yamashita T., Ando Y. Clinicopathological and biochemical findings of late-onset hereditary transthyretin amyloidosis 16 years after liver transplantation: an autopsy case study. Amyloid, 2017, in press.

 

15. Morimoto N., Takahashi S., Inaba T., Takamiya M., Kageyama Y., Morimoto M., Takahashi Y., Nishimura H., Nakane S., Abe K. A case of seropositive autoimmune autonomic ganglionopathy with diffuse esophageal spasm. J. Clin. Neurosci., 2017, in press.

 

16. Nakane S., Furutani K., Harada M., Urushihara R., Matsui N., Izumi Y., Kaji R. Multimodal analysis based on high-field magnetic resonance and motor evoked potentials. Clin. Exp. Neuroimmunol., 2017, in press.

 

17. Nishi S., Muso E., Shimizu A., Sugiyama H., Yokoyama H., Ando Y., Goto S., Fujii H. A clinical evaluation of renal amyloidosis in the Japan renal biopsy registry: a cross-sectional study. Clin. Exp. Nephrol. 2017, in press.

 

18. Nomura T., Yamashita T., Misumi Y., Ueda M., Masuda T., Tasaki M., Ando Y. A case with a novel variant transthyretin A36D presenting cardiac phenotype. Amyloid, 2017, in press.

 

19. Obayashi K., Ueda M., Yamashita T., Tasaki M., Izaki A., Yanagisawa Y., Masuda T., Misumi Y., Ando Y. Long-term effects of liver transplantation on small-fiber dysfunction in Japanese transthyretin (TTR)-related familial amyloidotic polyneuropathy (FAP) ATTR V30M. Amyloid, 2017, in press.

 

 

20. Oda S., Utsunomiya D., Nakaura T., Yuki H., Kidoh M., Morita K., Takashio D., Yamamuro M., Izumiya Y., Hirakawa K., Ishida T., Tsujita K., Ueda M., Yamashita T., Ando Y., Hata H., Yamashita Y. Identification and assessment of cardiac amyloidosis by myocardial strain analysis of cardiac magnetic resonance imaging. Circ. J., 2017, in press.

 

 

21. Sakai W., Nakane S., Urasaki E., Toyoda K., Sadakata E., Nagaishi A., Fukudome T., Yamakawa Y., Matsuo H. The Cross-Sectional Area of Paraspinal Muscles Predicts the Efficacy of Deep Drain Stimulation for Camptocormia. J. Parkinsons Dis., 2017, in press.

 

22. Singu T., Inatomi Y., Yonehara T., Ando Y. Calcified Amorphous Tumor Causing Shower Embolism to the Brain: A Case Report with Serial Echocardiographic and Neuroradiologic Images and a Review of the Literature. J. Stroke Cerebrovasc. Dis., 2017, in press.

 

 

23. Smith E., Cieslak A., Barber B., Chen Y., Chen J., Donnini I., Edwards J., Field TS., Frayne R., Hegedus J., Hanganu V., Ismail Z., Kanji J., Nakajima M., Noor R., Peca S., Sahlas D., Sharma M., Sposato L., Swartz R., Zerna C., Black S., Hachinski V. Therapeutic strategies and drug development for vascular cognitive impairment. J. Am. Heart Assoc., 2017, in press.

 

24. Tasaki M., Ueda M., Obayashi K., Kinoshita Y., Matsumoto S., Mizukami M., Masuda T., Misumi Y., Yamashita T., Ando Y. Identification of amyloid precursor protein from autopsy and biopsy specimens using LMD-LC-MS/MS: the experience in Kumamoto University. Amyloid, 2017, in press.

 

25. Tawara N., Yamashita S., Zhang X., Korogi M., Zhang Z., Doki T., Matsuo Y., Nakane S., Maeda S., Sugie K., Suzuki N., Aoki M., Ando Y. Pathomechanisms of anti-cN1A autoantibodies in sporadic inclusion body myositis. Ann. Neurol., 2017, in press.

 

26. Tsuda Y., Misumi Y., Ueda M., Tasaki M., Huang G., Masuda T., Suenaga G., Inoue Y., Kinoshita Y., Obayashi K., Yamashita T., Ando Y. Iatrogenic systemic transthyretin amyloid deposits in a case with domino liver transplantation: an autopsy case study. Amyloid, 2017, in press.

 

27. Yamamoto F., Yamashita S., Kawano H., Tanigawa T., Mihara Y., Gonoi T., Ando Y. Meningitis and ventriculitis due to Nocardia araoensis infection. Intern. Med. 2017, in press.

 

28. Yamashita T., Ueda M., Tasaki M., Masuda T., Misumi Y., Takamatsu K., Obayashi K., Ando Y. Establishment of a diagnostic center for amyloidosis in Japan by Kumamoto University. Amyloid, 2017, in press.

 

29. Yanagisawa Y., Obayashi K., Tasaki M., Izaki A., Masuda T., Misumi Y., Ueda M., Yamashita T., Ando Y. Clinicopathological characteristics of a patient with ureteral amyloidosis. Amyloid, 2017, in press.

 

30. Watanabe T., Obayashi K., Misumi Y., Tasaki M., Shinriki S., Ando T., Akagami T., Ueda M., Yamashita T., Hirotani S., Ando Y. Hereditary transthyretin amyloidosis associated with a transthyretin variant Thr59Arg. Amyloid, 2017, in press.

 

31. Ando T., Goto Y., Mano K., Ueda A., Ando Y., Mizuta I., Mizuno T. CADASIL Presenting as Acute Bilateral Multiple Subcortical Infarcts without a Characteristic Temporal Pole or Any External Capsule Lesions. Intern. Med. 55, 2873-2876, 2016.

 

 

32. Ando Y., Sekijima Y., Obayashi K., Yamashita T., Ueda M., Misumi Y., Morita H., Machii K., Ohta M., Takata A., Ikeda S., Effects of tafamidis treatment on transthyretin (TTR) stabilization, efficacy, and safety in Japanese patients with familial amyoid polyneuropathy (TTR-FAP) with Val30Met and non-Varl30Met: A phase III, open-label study. J. Neurol. Sci. 15, 266-271, 2016.

 

33. Asakura K., Yanai S., Nakamura S., Kawaski1 K., Eizuka M., Ishida K., Sugai T., Ueda M., Yamashita T., Ando Y., Matsumoto T. Endoscopic Findings of Small-Bowel Lesions in Familial Amyloid Polyneuropathy: A Case Report. Medicine (Baltimore) 95, e2896, 2016.

 

34. Azuma M., Hirai T., Yamada K., Yamashita S., Ando Y., Tateishi M., Iryo Y., Yoneda T., Kitajima M., Wang Y., Yamashita Y. Lateral asymmetry and spatial difference of iron deposition in the substantia nigra of patients with parkinson disease measured with quantitative susceptibility mapping. AJNR Am. J. Neuroradiol. 37, 782-788, 2016.

 

35. Fukasawa K., Higashimoto Y., Motomiya Y., Uji Y., Ando Y. Influence of heparin molecular size on the induction of C- terminal unfolding in β2-microglobulin. Mol. Biol. Res. Commun. 5, 225-232, 2016.

 

36. Higuchi O., Nakane S., Sakai W., Maeda Y., Niino M., Takahashi T., Fukazawa T., Kikuchi S., Fujihara K., Matsuo H. Lack of KIR4.1 autoantibodies in Japanese patients with MS and NMO. Neurol. Neuroimmunol. Neuroinflamm. 3, e263, 2016.

 

37. Hosoi A., Su Y., Torikai M., Jono H., Ishikawa D., Soejima K., Higuchi H., Guo J., Ueda M., Suenaga G., Motokawa H., Ikeda T., Senju S., Nakashima T., Ando Y. Novel Antibody for the Treatment of Transthyretin Amyloidosis. J. Biol. Chem. 25, 25096-25105, 2016.

 

38. Inoue Y., Nakajima M., Uetani H., Hirai T., Ueda M., Kitajima M., Utsunomiya D., Watanabe M., Hashimoto M., Ikeda M., Yamashita Y., Ando Y. Diagnostic significance of cortical superficial siderosis for Alzheimer’s disease in patients with cognitive impairment. AJNR Am. J. Neuroradiol. 37, 223-227, 2016.

 

39. Inoue Y., Nakajima M., Hirai T., Ando Y. Reply. AJNR Am J Neuroradiol. 37, E26, 2016.

 

40. Ishizaki M., Kedoin C., Ueyama H., Maeda Y., Yamashita S., Ando Y. Utility of skinfold thickness measurement in non-ambulatory patients with Duchenne muscular dystrophy. Neuromuscul. Disord. 27, 24-28, 2017.

 

41. Jono H., Su Y., Obayashi K., Tanaka Y., Ishiguro A., Nishimura H., Shinriki S., Ueda M., Ikeda K., Yamagata K., Ichihara K., Ando Y., Scientific Committee for the Asia-Pacific Federation of Clinical Biochemistry. Sources of variation of transthyretin in healthy subjects in East and Southeast Asia: Clinical and experimental evidence for the effect of alcohol on transthyretin metabolism. Clin. Chim. Acta. 458, 5-11, 2016.

 

42. Kamada M., Nakane S., Matsui N., Higuchi O., Sakai W., Fujita K., Izumi Y., Matsuo H., Kaji R. Ocular myasthenia gravis with anti-muscle-specific tyrosine kinase antibodies: Two new cases and a systematic literature review. Clin Exp Neuroimmunol, 7, 168-173, 2016.

 

43. Kasagi T., Nobata H., Suzuki K., Miura N., Banno S., Takami A., Yamashita T., Ando Y., Imai H. Light Chain Deposition Disease Diagnosed with Laser Micro-dissection, Liquid Chromatography, and Tandem Mass Spectrometry of Nodular Glomerular Lesions. Intern. Med. 56, 61-66, 2017.

 

44. Kawano H., Bivard A., Lin L., Spratt N., Miteff F., Parsons M., Levi C. The relationship between collateral status, contrast transit and contrast density in acute ischemic stroke. Stroke 47, 742-749, 2016.

 

45. Kawano H., Levi C., Inatomi Y., Pagram H., Kerr E., Bivard A., Spratt N., Miteff F., Yonehara T., Ando Y., Parsons M. International benchmarking for acute thrombolytic therapy implementation in Australia and Japan. J. Clin. Neurosci. 29, 87-91, 2016.

 

46. Kikukawa Y., Hata H., Ueda M., Yamashita T., Nasu S., Ide K., Ueno S., Ando Y., Mitsuya H., Okuno Y. Successful Treatment of Amyloid Light-chain Amyloidosis in a Charcot-Marie-Tooth Disease Patient with Lenalidomide, Cyclophosphamide, and Dexamethasone. Intern. Med. 55, 2707-2712, 2016.

 

47. Kimura T., Fukushima S., Miyashita A., Aoi J., Jinnin M., Kosaka T., Ando Y., Matsukawa M., Inoue H., Kiyotani K., Park JH., Nakamura Y., Ihn H. Myasthenic crisis and polymyositis induced by one dose of nivolumab. Cancer Sci. 107, 1055-1058, 2016.

 

48. Koike H., Ikeda S., Takahashi M., Kawagashira Y., Iijima M., Misumi Y., Ando Y., Ikeda SI., Katsuno M., Sobue G. Schwann cell and endothelial cell damage in transthyretin familial amyloid polyneuropathy. Neurology 87, 2220-2229, 2016.

 

49. Kuki I., Kawawaki H., Okazaki S., Hattori Y., Horino A., Higuchi O., Nakane S. Autoimmune autonomic ganglionopathy in a pediatric patient presenting with acute encephalitis. Brain Dev. 38, 605-608, 2016.

 

50. Kukidome D., Nishikawa T., Sato M., Igata M., Kawashima J., Shimoda S., Matsui K., Obayashi K., Ando Y., Araki E. Measurement of small fibre pain threshold values for the early detection of diabetic polyneuropathy. Diabet. Med. 33, 62-9, 2016.

 

51. Maeda Y., Migita K., Higuchi O., Mukaino A., Furukawa H., Komori A., Nakamura M., Hashimoto S., Nagaoka S., Abiru S., Yatsuhashi H., Matsuo H., Kawakami A., Yasunami M., Nakane S. Association between Anti-Ganglionic Nicotinic Acetylcholine Receptor (gAChR) Antibodies and HLA-DRB1 Alleles in the Japanese Population. PLoS One. 11, e0146048, 2016.

 

52. Masuda T., Obayashi K., Ueda M., Fujimoto A., Tasaki M., Misumi Y., Ueda A., Nakane T., Yamashita T., Ando Y. Therapeutic effects and prevention of recurrence of acquired idiopathic generalized anhidrosis via i.v. immunoglobulin treatment. J. Dermatol. 43, 336-337, 2016.

 

53. Merlini G., Lousada I., Ando Y., Dispenzieri A., Gertz MA., Grogan M., Maurer MS., Sanchorawala V., Wechalekar A., Palladini G., Comenzo RL. Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis. Leukemia 30, 1979-1986, 2016.

 

54. Misumi Y., Narita Y., Oshima T., Ueda M., Yamashita T., Tasaki M., Obayashi K., Isono K., Inomata Y., Ando Y. Recipient Aging Accelerates Acquired Transthyretin Amyloidosis After Domino Liver Transplantation. Liver Transpl. 22, 656-664, 2016.

 

55. Mori A., Yamashita S., Nakajima M., Hori H., Tawara A., Matsuo Y., Misumi Y., Ando Y. CMAP decrement as a potential diagnostic marker for ALS. Acta. Neurol. Scand. 134, 49-53, 2016.

 

56. Mori Y., Yamashita S., Kato M., Masuda T., Takamatsu K., Kumamoto T., Sasaki R., Ando Y. Thomsen disease with ptosis and abnormal MR findings. Neuromuscul. Disord. 26, 805-808, 2016.

 

57. Mukaino A., Nakane S., Higuchi O., Nakamura H., Miyagi T., Shiroma K., Tokashiki T., Fuseya Y., Ochi K., Umeda M., Nakazato T., Akioka S., Maruoka H., Hayashi M., Igarashi S., Yokoi K., Maeda Y., Sakai W., Matsuo H., Kawakami A. Insights from the ganglionic acetylcholine receptor autoantibodies in patients with Sjögren’s syndrome. Mod. Rheumatol. 26, 708-715, 2016.

 

58. Nakane S., Izumi Y., Oda M., Kaji R., Matsuo H. A Potential Link between Amyotrophic Lateral Sclerosis and Bullous Pemphigoid: Six New Cases and a Systematic Review of the Literature. Intern. Med. 55, 1985-1990, 2016.

 

59. Nakane S., Higuchi O., Hamada Y., Maeda Y., Mukaino A., Sakai W., Kusunoki S., Matsuo H. Ganglionic acetylcholine receptor autoantibodies in patients with Guillain-Barré syndrome. J. Neuroimmunol. 15, 295-296, 2016.

 

60. Nakane S., Mukaino A., Maeda Y., Higuchi O., Matsuo H., Ando Y. Extra-autonomic manifestations in autoimmune autonomic ganglionopathy: a Japanese survey. J. Neurol. Neurosurg. Psychiatry 88, 367-368, 2017.

 

61. Nakahara K., Nakane S., Nakajima M., Yamashita S., Mori T., Ando Y. Effect of thymectomy for thymic atrophy in myasthenia gravis: A retrospective study on 93 patients. J. Neuroimmunol. 305, 182-185, 2017.

 

62. Obayashi K., Ando Y., Araki E. Kukidome D., Nishikawa T., Sato M., Igata M., Kawashima J., Shimoda S., Matsui K., Measurement of small fibre pain threshold values for the early detection of diabetic polyneuropathy. Diabet. Med. 33, 62-69, 2016.

 

63. Okumura K., Yamashita T., Masuda T., Misumi Y., Ueda A., Ueda M., Obayashi K., Jono H., Yamashita S., Inomata Y., Ando Y. Long-term outcome of patients with hereditary transthyretin V30M amyloidosis with polyneuropathy after liver transplantation. Amyloid, 23, 39-45, 2016.

 

64. Shimazaki C., Fuchida S., Suzuki K., Ishida T., Imai H., Sawamura M., Takamatsu H., Abe M., Miyamoto T., Hata H., Yamada M., Ando Y. Phase 1 study of bortezomib in combination with melphalan and dexamethasone in Japanese patients with relapsed AL amyloidosis. Int. J. Hematol. 103, 79-85, 2016.

 

65. Shindo S., Fujii K., Shirakawa M., Uchida K., Sugiura Y., Saito S., Ando Y., Yoshimura S. Three-Dimensional Optical Frequency Domain Imaging Evaluation of Novel Dual-Layered Carotid Stent Implantation for Vulnerable Carotid Plaque. J Stroke Cerebrovasc. Dis. 25, e31-32, 2016.

 

66. Suenaga G., Ikeda T., Komohara Y., Takamatsu K., Kakuma T., Tasaki M., Misumi Y., Ueda M., Ito T., Senju S., Ando Y. Involvement of Macrophages in the Pathogenesis of Familial Amyloid Polyneuropathy and Efficacy of Human iPS Cell-Derived Macrophages in Its Treatment. PLoS One 11, e0163944, 2016.

 

67. Sugimura Y., Hoshino H. Difficulty in Applying Recombinant Tissue Plasminogen Activator (rt-PA). Intern. Med. 55, 1027-8, 2016.

 

68. Sugimura Y., Koike K., Terao S., Asada H. Good outcome case of anterior cerebral artery dissection that was treated with recombinant tissue plasminogen activator and trapping with A3-A3 anastomosis surgery. Neurol. Clin. Neurosci. 4, 5, 2016.

 

69. Suzuki N., Mori-Yoshimura. M., Yamashita S., Nakano S., Murata KY., Inamori Y., Matsui N., Kimura E., Kusaka H., Kondo T., Higuchi I., Kaji R., Tateyama M., Izumi R., Ono H., Kato M., Warita H., Takahashi T., Nishino I., Aoki M. Multicenter questionnaire survey for sporadic inclusion body myositis in Japan. Orphanet J. Rare Dis. 11, 146, 2016.

 

70. Suzuki T., Kusumoto S., Yamashita T., Masuda A., Kinoshita S., Yoshida T., Takami-Mori F., Takino H., Ito A., Ri M., Ishida T., Komatsu H., Ueda M., Ando Y., Inagaki H., Iida S. Labial salivary gland biopsy for diagnosing immunoglobulin light chain amyloidosis: a retrospective analysis. Ann. Hematol. 95, 279-285, 2016.

 

71. Takahashi H., Noto YI., Makita N., Kushimura-Okada Y., Ishii R., Tanaka A., Ohara T., Nakane S., Higuchi O., Nakagawa M., Mizuno T. Myasthenic symptoms in anti-low-density lipoprotein receptor-related protein 4 antibody-seropositive amyotrophic lateral sclerosis: two case reports. BMC Neurol. 16, 229, 2016.

 

72. Tasaki M., Ueda M., Obayashi K., Motokawa H., Kinoshita Y., Suenaga G., Yanagisawa A., Toyoshima R., Misumi Y., Masuda T., Yamashita T., Ando Y. Rapid detection of wild-type and mutated transthyretins. Ann. Clin. Biochem. 53, 508-510, 2016.

 

73. Tokunaga M., Beppu A., Tamura Y., Oowaki K., Tokunaga Y., Ishihara C., Shibata K., Tanaka K., Takayama M. Relationship between improvement in GNRI, a nutritional index, and improvement in motor FIM in elderly stroke patients hospitalized in a Kaifukuki Rehabilitation Ward. Jpn. J. Compr. Rehabil. Sci. 7, 7-12, 2016.

 

74. Tokunaga M., Mori Y., Ogata Y., Tanaka Y., Uchino K., Maeda Y., Kamiyoshi M. Predicting FIM gain in stroke patients by adding median FIM gain stratified by FIM score at hospital admission to the explanatory variables in multiple regression analysis –An analysis of the Japan Rehabilitation Detabase-. Jpn. J. Compr. Rehabil. Sci. 7, 13-18, 2016.

 

75. Tsuji W., Takeuchi E., Oka S., Yamashita T., Yotsumoto F. Localized primary amyloidosis of the breast: a case report and review of the literature. BMC Surg. 16, 62, 2016.

 

76. Yamashita T., Ueda M., Saga N., Nanto K., Tasaki M., Masuda T., Misumi Y., Oda S., Fujimoto A., Amano T., Takamatsu K., Yamashita S., Obayashi K., Matsui H., Ando Y. Hereditary amyloidosis with cardiomyopathy caused by the novel variant transthyretin A36D. Amyloid 23, 207-208, 2016.

 

77. Yanagisawa A., Ueda M., Sueyoshi T., Nakamura E., Tasaki M., Suenaga G., Motokawa H., Toyoshima R., Kinoshita Y., Misumi Y., Yamashita T., Sakaguchi M., Westermark P., Mizuta H., Ando Y. Knee osteoarthritis associated with different kinds of amyloid deposits and the impact of aging on type of amyloid. Amyloid, 23, 26-32, 2016.

 

78. Yoshimura Y., Kuwabara T., Shiraishi N., Kakizoe Y., Tasaki M., Obayashi K., Ando Y., Mukoyama M. Transthyretin-related familial amyloidotic polyneuropathy found with abnormal urinalysis at a general health checkup. Nephrology (Carlton) 21, 341-342, 2016.

 

Copyright© Department of Neurology, Graduate School of Medical Sciences, Kumamoto University.